Biblioteca Humberto Rosselli Quijano
Resultado de la búsqueda
1 búsqueda de la palabra clave
'Antipsicóticos, Benzodiazepinas, Pirenzepina, Esquizofrenia.' ![Resaltar las palabras buscadas Resaltar las palabras buscadas](./images/text_horizontalrule.png)
![](./images/expand_all.gif)
![](./images/collapse_all.gif)
![Imprimer la page de recherche courante...](./images/print.gif)
![Selecciones disponibles](./images/orderby_az.gif)
Olanzapine plasma concentrations and clinical response: acute phase results of the north american olanzapine trial / Paul J. Perry en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 1 (Febrero)
[artículo]
Título : Olanzapine plasma concentrations and clinical response: acute phase results of the north american olanzapine trial Tipo de documento: texto impreso Autores: Paul J. Perry, Autor ; Brian C. Lund, Autor ; Todd Sanger, Autor Fecha de publicación: 2023 Artículo en la página: pp. 14-20 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Esquizofrenia. Resumen: Olanzapine is an atypical antipsychotic that is effective in the treatment of schizophrenia. Olanzapine plasma concentrations ≥ 9.3 ng/mL (24 hours postdose) have been identified as a predictor of clinical response in acutely ill patients with schizophrenia. The authors report a receiver operating characteristic (ROC) curve analysis of 12-hour olanzapine concentrations and treatment response from the North American Double-Blind Olanzapine Trial. Link: ./index.php?lvl=notice_display&id=31132
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 14-20[artículo] Olanzapine plasma concentrations and clinical response: acute phase results of the north american olanzapine trial [texto impreso] / Paul J. Perry, Autor ; Brian C. Lund, Autor ; Todd Sanger, Autor . - 2023 . - pp. 14-20.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 14-20
Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Esquizofrenia. Resumen: Olanzapine is an atypical antipsychotic that is effective in the treatment of schizophrenia. Olanzapine plasma concentrations ≥ 9.3 ng/mL (24 hours postdose) have been identified as a predictor of clinical response in acutely ill patients with schizophrenia. The authors report a receiver operating characteristic (ROC) curve analysis of 12-hour olanzapine concentrations and treatment response from the North American Double-Blind Olanzapine Trial. Link: ./index.php?lvl=notice_display&id=31132